Top news of the week: 11.03.2021.
Startups
Ex-Intercept CMO Campagna lands at immune regulation biotech Q32
Jason Campagna has taken up the chief medical officer position (CMO) at Q32 Bio. Campagna arrives at Q32 after a stint at Intercept Pharmaceuticals that saw him rise to the CMO role at the ...
Quench Bio hit by 'successful failure,' winds down ops in Twitter thread as tech sold off at auction
Quench Bio’s short journey has come to an end after the biotech startup found that its target was simply undruggable.
Women Supporting Women: The Inspiring Story Behind One Of The 20th Century’s Least-Appreciated Innovations—The Sports Bra
Ahead of International Women’s Day, we share the 21 most inspiring and enduring Forbes articles on the female entrepreneurs and executives who have defined the 21st century so far.
Top 10 U.S. Biopharma Clusters
Judging from the numbers reported by the nation’s top U.S. clusters, 2020 saw record-high amounts of lab space and NIH funding, as well as record-high numbers of jobs and patents. ...
What a 3rd authorized vaccine means for the summer
These are Insider's biggest healthcare stories for the week ending March 5.
The Rise in Asian American Hate Crimes: A Biopharma Perspective and Call For Action
I have been a biopharma executive for 30 years. For the last 12 years, I’ve been living with Young-Onset Parkinson’s Disease. I have been an Asian American even longer…all my life. ...
Taking a page from Celgene, Takeda builds and buys a cancer biotech
An agreement to acquire Maverick Therapeutics for up to $525 million has roots in a plan hatched by Takeda to emulate elements of Celgene's dealmaking strategy.